Eiko LifeSciences Limited reported earnings results for the fourth quarter ended March 31, 2022. For the fourth quarter, the company reported sales was INR 52.92 million compared to INR 61.45 million a year ago. Revenue was INR 54.97 million compared to INR 62.82 million a year ago. Net income was INR 1.47 million compared to INR 3.55 million a year ago. Basic earnings per share from continuing operations was INR 0.18 compared to INR 0.93 a year ago. Diluted earnings per share from continuing operations was INR 0.18 compared to INR 0.93 a year ago.